
A British Startup Sends a Longevity Lab Into Orbit to Study Disease Proteins
A British startup launches microgravity research into orbit to study disease proteins and build AI tools for drug discovery.

A British startup launches microgravity research into orbit to study disease proteins and build AI tools for drug discovery.

Erling Haaland’s viral fake clip shows how AI sports fandom is turning athletes into remixable characters at the World Cup.

Anthropic is entering AI drug discovery with Claude Science and plans to pursue its own medicines, but the path to patients remains long.

Midjourney’s new medical scanner video shows more hardware, but little proof the ultrasound system can deliver on its bold health claims.

AI detection tools are fueling a fanfiction backlash on AO3, but the methods are shaky and risk flagging innocent writers.

Meta’s AI gaming app Pocket lets users build mini games with prompts, signaling a bigger push into social, AI-generated creativity.

Cursor acquisition by SpaceX raises a key AI question: can the coding platform stay open to OpenAI and Anthropic models?

Meta may sell AI compute and models through a new cloud business, turning massive infrastructure spending into revenue.

The Builders Stage agenda at Disrupt 2026 spotlights fundraising, AI, hiring and go-to-market lessons for founders trying to scale.

Ashton Kutcher leaves Sound Ventures to launch an AI infrastructure-focused VC firm with Morgan Beller, signaling a shift in AI investing.